Yara International ASA

DB:IU2 Stock Report

Market Cap: €6.8b

Yara International Valuation

Is IU2 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IU2 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: IU2 (€26.79) is trading below our estimate of fair value (€38.26)

Significantly Below Fair Value: IU2 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IU2?

Key metric: As IU2 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for IU2. This is calculated by dividing IU2's market cap by their current earnings.
What is IU2's PE Ratio?
PE Ratio13.1x
EarningsUS$548.00m
Market CapUS$7.20b

Price to Earnings Ratio vs Peers

How does IU2's PE Ratio compare to its peers?

The above table shows the PE ratio for IU2 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average40.2x
SDF K+S
78.5x61.1%€2.0b
EVK Evonik Industries
35.3x33.1%€8.1b
FPE3 Fuchs
18.6x8.7%€4.9b
WCH Wacker Chemie
28.3x37.0%€3.5b
IU2 Yara International
13.1x13.7%€79.6b

Price-To-Earnings vs Peers: IU2 is good value based on its Price-To-Earnings Ratio (13.1x) compared to the peer average (40.3x).

Price to Earnings Ratio vs Industry

How does IU2's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
IU2 13.1xIndustry Avg. 16.8xNo. of Companies12PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: IU2 is good value based on its Price-To-Earnings Ratio (13.1x) compared to the European Chemicals industry average (17.3x).

Price to Earnings Ratio vs Fair Ratio

What is IU2's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IU2 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13.1x
Fair PE Ratio16.6x

Price-To-Earnings vs Fair Ratio: IU2 is good value based on its Price-To-Earnings Ratio (13.1x) compared to the estimated Fair Price-To-Earnings Ratio (16.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst IU2 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€26.79
€30.04
+12.1%
14.8%€37.21€21.38n/a18
Nov ’25€27.66
€29.24
+5.7%
15.2%€36.30€20.86n/a18
Oct ’25€28.54
€29.56
+3.6%
14.8%€37.03€23.83n/a17
Sep ’25€26.40
€29.57
+12.0%
15.0%€37.11€23.03n/a17
Aug ’25€26.13
€29.79
+14.0%
15.6%€36.81€22.85n/a17
Jul ’25€26.74
€30.79
+15.1%
16.4%€38.04€23.61n/a17
Jun ’25€28.64
€31.16
+8.8%
15.8%€38.21€23.72n/a17
May ’25€26.91
€31.34
+16.5%
14.6%€37.92€23.66n/a17
Apr ’25€29.33
€32.57
+11.0%
11.7%€37.52€25.63n/a17
Mar ’25€29.88
€33.87
+13.4%
11.6%€38.16€26.31n/a17
Feb ’25€30.90
€33.95
+9.9%
14.5%€40.53€22.91n/a16
Jan ’25€32.09
€35.45
+10.5%
13.3%€42.35€26.75n/a16
Dec ’24€31.20
€34.44
+10.4%
13.4%€40.94€25.86n/a16
Nov ’24€30.88
€34.09
+10.4%
12.8%€40.19€27.08€27.6616
Oct ’24€36.00
€36.79
+2.2%
13.1%€44.65€28.30€28.5417
Sep ’24€33.86
€35.87
+5.9%
13.4%€43.91€27.83€26.4018
Aug ’24€36.69
€36.69
+0.005%
13.2%€45.04€28.54€26.1318
Jul ’24€32.47
€36.99
+13.9%
13.2%€44.40€28.17€26.7418
Jun ’24€35.13
€37.14
+5.7%
12.8%€44.14€29.43€28.6418
May ’24€36.95
€38.75
+4.9%
13.4%€45.83€30.55€26.9118
Apr ’24€39.99
€41.59
+4.0%
12.4%€48.45€31.71€29.3318
Mar ’24€44.15
€43.76
-0.9%
11.2%€49.68€32.52€29.8817
Feb ’24€41.00
€43.71
+6.6%
10.5%€51.41€34.89€30.9017
Jan ’24€41.09
€45.29
+10.2%
11.4%€53.39€36.23€32.0917
Dec ’23€44.41
€46.59
+4.9%
11.8%€54.67€37.10€31.2017
Nov ’23€45.32
€46.82
+3.3%
11.4%€54.76€37.16€30.8817

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Arkema

€5.7b

Manufactures and sells specialty chemicals and advanced materials worldwide.

V1S

€74.85

7D

0.4%

1Y

-19.9%

Minerals Technologies

US$2.6b

Develops, produces, and markets various mineral, mineral-based, and related systems and services.

MNK

US$74.50

7D

1.4%

1Y

33.0%

Cabka

€60.3m

Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.

7GW

€2.38

7D

-7.8%

1Y

-61.1%